Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
BMC Cancer|February 6, 2020
A decrease in brown adipose tissue activity is associated with weight gain during chemotherapy in early breast cancer patientsAngeline Ginzac, Bertrand Barres, Marion Chanchou, et al.
Clinical Nutrition ESPEN|January 29, 2025
Relationship between muscular mass, inflammatory status, tumor metabolic activity and oral intake in head and neck cancer at the outset of managementMathilde Rey, Olivier le Bacquer, Aurélien Mulliez, et al.
EJNMMI Radiopharmacy and Chemistry|June 1, 2026
Development of an automated radiosynthesis for [68Ga]Ga-NODAGA[40Lys]-Exendin-4 in sodium acetate bufferMaïlys Ragot, Pauline Reynaud-Orhon, Alban Revy, et al.
EJNMMI Research|May 25, 2023
Imaging quality of an artificial intelligence denoising algorithm: validation in 68Ga PSMA-11 PET for patients with biochemical recurrence of prostate cancerCharles Margail, Charles Merlin, Tommy Billoux, et al.
Frontiers in Medicine|March 8, 2021
Decision Tree With Only Two Musculoskeletal Sites to Diagnose Polymyalgia Rheumatica Using [18F]FDG PET-CTAnthime Flaus, Julie Amat, Nathalie Prevot, et al.
Andrology|January 28, 2026
Effects of Low-to-Moderate Ionizing Radiation on Human Sperm Function and DNA IntegrityOriana Carcy, Nicolas Sas, Marion Chanchou, et al.
Frontiers in Medicine|September 14, 2020
Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography in Inflammatory Rheumatism, Particularly Polymyalgia Rheumatica: A Retrospective Study of 222 PET/CTJulie Amat, Marion Chanchou, Louis Olagne, et al.
EJNMMI Research|September 26, 2025
[99mTc]Tc-NTP 15 - 5, a new proteoglycan tracer for functional imaging of joint cartilage: phase I (CARSPECT)Marion Chanchou, Emilie Thivat, Sylvain Mathieu, et al.
Clinical Nuclear Medicine|June 13, 2022
Delayed [ 18 F]-FDG PET Imaging Increases Diagnostic Performance and Reproducibility to Differentiate Recurrence of Brain Metastases From RadionecrosisHosameldin Otman, Julien Farce, Pierre Meneret, et al.
BMC Cancer|April 16, 2022
Phase I study of [131I] ICF01012, a targeted radionuclide therapy, in metastatic melanoma: MELRIV-1 protocolEmilie Thivat, Jacques Rouanet, Philippe Auzeloux, et al.
Pageof 2